Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosis.

[1]  T. Chiba,et al.  Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis. , 2013, Gastroenterology.

[2]  Masakazu Yamamoto,et al.  Disease recurrence plays a minor role as a cause for retransplantation after living‐donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  K. Hasegawa,et al.  Long‐term outcome of living donor liver transplantation for primary biliary cirrhosis , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  D. Samuel,et al.  Significance of isolated hepatic veno‐occlusive disease/sinusoidal obstruction syndrome after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  V. Paradis,et al.  Obliterative portal venopathy: portal hypertension is not always present at diagnosis. , 2011, Journal of hepatology.

[6]  K. Shirabe,et al.  Living donor hepatectomies with procedures to prevent biliary complications. , 2010, Journal of the American College of Surgeons.

[7]  Rajeev Sharma,et al.  Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database , 2010, Journal of Gastrointestinal Surgery.

[8]  R. Wiesner,et al.  Recurrent Primary Biliary Cirrhosis After Liver Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  A. Burroughs,et al.  Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  Y. Maehara,et al.  Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. , 2009, Journal of the American College of Surgeons.

[11]  M. Makuuchi,et al.  Recurrence of cholestatic liver disease after living donor liver transplantation. , 2008, World journal of gastroenterology.

[12]  R. Wiesner,et al.  Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database , 2008, Hepatology.

[13]  J. Neuberger,et al.  The impact of disease recurrence on graft survival following liver transplantation: a single centre experience , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  C. Daskalakis,et al.  Human leukocyte antigen and adult living‐donor liver transplantation outcomes: An analysis of the organ procurement and transplantation network database , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  T. Manabe,et al.  Histological recurrence of autoimmune liver diseases after living‐donor liver transplantation , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[16]  Masakazu Yamamoto,et al.  Long‐term clinical outcome of living‐donor liver transplantation for primary biliary cirrhosis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  R. Wiesner,et al.  Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  H. Shimada,et al.  Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  A. Krasinskas,et al.  Liver Transplantation in Precirrhotic Biliary Tract Disease: Portal Hypertension is Frequently Associated With Nodular Regenerative Hyperplasia and Obliterative Portal Venopathy , 2006, The American journal of surgical pathology.

[20]  F. Reinholt,et al.  Liver biopsy interpretation for causes of late liver allograft dysfunction , 2006, Hepatology.

[21]  U. Neumann,et al.  Long‐term follow‐up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients , 2006, Clinical transplantation.

[22]  米村 祐輔,et al.  Validity of preoperative volumetric analysis of congestion volume in living donor liver transplantation using three-dimensional computed tomography , 2006 .

[23]  Z. Ben‐Ari.  Life-threatening veno-occlusive disease after living-related liver transplantation. , 2003, Transplantation.

[24]  J. Pomposelli,et al.  Liver transplantation for primary biliary cirrhosis: A long‐term pathologic study , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  J. Ludwig,et al.  Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow‐up study , 2001, Liver transplantation.

[26]  J. Neuberger,et al.  Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center , 2001, Hepatology.

[27]  R. Wiesner,et al.  Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection , 2000, Hepatology.

[28]  R. C. Chang,et al.  Using three-dimensional-computerized tomography as a diagnostic tool for temporo-mandibular joint ankylosis: a case report. , 1999, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[29]  K. Lazaridis,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[30]  Randall G. Lee,et al.  Banff schema for grading liver allograft rejection: An international consensus document , 1997, Hepatology.

[31]  Y. Nakanuma,et al.  Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. , 1982, The American journal of gastroenterology.